47.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bristol Myers Squibb Co Borsa (BMY) Ultime notizie
Bristol Myers Squibb (BMY) Gains EU Approval for Breyanzi in Man - GuruFocus
Bristol-Myers Squibb Says Money Motivated Texas Plavix Suit - Bloomberg Law News
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study - Benzinga
Bristol Myers (BMY) Sees Stock Surge on Positive Drug Trial News - GuruFocus
Prudential Financial Inc. Purchases 2,334,421 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Cantor Fitzgerald reiterates neutral rating on Bristol-Myers stock - Investing.com India
Cantor Fitzgerald maintains Bristol-Myers Squibb stock rating, cites milvexian potential - Investing.com India
Novo Nordisk, Bristol-Myers and Uber rose premarket; Performance Food falls - Investing.com
Heron Bay Capital Management Has $977,000 Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Mufg Securities Americas Inc. Purchases 9,182 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
14,187 Shares in Bristol Myers Squibb Company $BMY Acquired by Neo Ivy Capital Management - MarketBeat
Brandywine Global Investment Management LLC Sells 633,786 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Legal & General Group Plc Sells 707,829 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Crashes Again: Another Trial Failure Shocks Investors - Smartkarma
Texas AG Sues Sanofi And Bristol-Myers Over Alleged Failures To Warn About Risks Associated With Blood Thinner Drug - Benzinga
Texas Attorney General Ken Paxton Sues Sanofi, Bristol-Myers Squibb - Hoodline
Quilter Plc Lowers Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Has $106.03 Million Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb stock holds steady as BMO reiterates $47 target By Investing.com - Investing.com South Africa
Bristol-Myers Squibb: Navigating Challenges in a Critical Transition Phase - Ad-hoc-news.de
Texas Sues Bristol-Myers For Alleged Drug Misrepresentations - Law360
Merck, Bristol Myers Squibb plan NJ layoffs (updated) - NJBIZ
State of Texas Sues Bristol-Myers Squibb and Sanofi for Deceptive Marketing of Blood Thinner Plavix - cnhinews.com
Texas sues Bristol Myers, Sanofi for concealing blood thinner Plavix's alleged ineffectiveness - Reuters
Bristol-Myers, Sanofi Draw Texas Fraud Claims Over Plavix Safety - Bloomberg Law News
Bristol-Myers Squibb (BMY) Faces Legal Action Over Plavix Effectiveness Claims - GuruFocus
Bristol Myers, Sanofi sued by Texas over Plavix - Yahoo
What's Driving the Market Sentiment Around Bristol-Myers Squibb Co? - Benzinga
Buy Bristol Myers Squibb Stock. The Drugmaker Is Too Cheap to Ignore. - Barron's
Bristol-Myers Squibb stock holds steady as BMO reiterates $47 target - Investing.com India
Traub Capital Management LLC Acquires New Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
2 Major Pharmaceutical Companies Laying Off Hundreds More In NJ - Patch
Vanguard Group Inc. Has $9.02 Billion Stake in Bristol Myers Squibb Company $BMY - MarketBeat
WBI Investments LLC Acquires New Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company (BMY) Slipped due to Lowered EPS Guidance - Yahoo Finance UK
Primecap Management Co. CA Trims Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Business development leadership team - Bristol Myers Squibb
Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared To Competitors - 富途牛牛
Is Bristol Myers Squibb Company (BRM) stock a contrarian opportunityM&A Rumor & High Win Rate Trade Tips - newser.com
Pharma giant gave Irish employee three months to come up with €20,800 to cover alleged ‘overpayment’, WRC hears - The Irish Times
Will Bristol Myers Squibb Company (BRM) stock beat growth indexesMarket Activity Summary & Fast Gain Swing Alerts - newser.com
Published on: 2025-11-19 14:34:44 - newser.com
Metabolic Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 576 Deals by Company A-Z, Therapy Focus and Technology Type - GlobeNewswire Inc.
Is Bristol Myers Squibb Company Celegne Contingent stock resilient in recession scenariosWeekly Gains Summary & Safe Entry Point Identification - newser.com
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know - Yahoo Finance UK
Is Bristol Myers Squibb Company stock oversold or undervaluedJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Nordwand Advisors LLC Acquires New Position in Bristol Myers Squibb Company $BMY - MarketBeat
Nomura Asset Management Co. Ltd. Boosts Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Empowered Funds LLC Lowers Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Biokin/BMS’s Iza-bren Hits First Phase III OS Endpoint, Albeit In China - Citeline News & Insights
Will Bristol Myers Squibb Company Celegne Contingent stock benefit from mergersWeekly Investment Report & Free Risk Controlled Daily Trade Plans - newser.com
Bristol-Myers Squibb (BMY) Announces Early Results and Amendments to Cash Tender Offers - GuruFocus
How Bristol Myers Squibb Company stock reacts to new regulationsRate Cut & Verified Momentum Watchlists - newser.com
Bristol-Myers Squibb Can Appeal Pension Suit To 2nd Circ. - Law360
Merck & Co., BMS to lay off over 300 staffers in New Jersey - FirstWord Pharma
What dividend safety rating applies to Bristol Myers Squibb Company stockJuly 2025 Price Swings & Fast Entry Momentum Trade Alerts - newser.com
Bristol Myers Squibb announces pricing terms for debt tender offers - Investing.com
Bristol Myers Squibb announces pricing terms for debt tender offers By Investing.com - Investing.com India
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers - Business Wire
Knott David M Jr Purchases 8,000 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Merck, Bristol announce additional layoffs in New Jersey - Seeking Alpha
Universal Beteiligungs und Servicegesellschaft mbH Raises Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Thoroughbred Financial Services LLC Cuts Stock Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Why Bristol-Myers Squibb Remains Undervalued In 2025 (NYSE:BMY) - Seeking Alpha
Integrated Quantitative Investments LLC Invests $495,000 in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY is Chiron Capital Management LLC's Largest Position - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):